Navigation Links
A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments
Date:7/25/2014

Port Washington, NY (PRWEB) July 25, 2014

Parker Waichman LLP, a national law firm dedicated to protecting the rights of consumers comments on a recent tobacco lawsuit in which a Florida jury awarded the widow of a smoker $23.6 billion in punitive damages. Cynthia Robinson brought the lawsuit against R.J. Reynolds, which manufactures Kool brand cigarettes. The case is Cynthia Robinson v. R.J. Reynolds Tobacco Company and was brought in 2008 in the Florida First Circuit Court, Escambia County, Florida; Case Number 2008 CA 000098.

Mrs. Robinson brought the lawsuit on behalf of her now-deceased husband, Michael Johnson Sr. who chain-smoked cigarettes and allegedly began smoking at the age of 13, according to a Time reported dated July 21, 2014. The lawsuit, considered one of the so-called “Engle Progeny,” also alleges that the cigarettes smoked by Mr. Robinson were both defective and unreasonably dangerous. According to a report issued by the Pensacola News Journal, dated July 20, 2014, Mr. Johnson became addicted to cigarettes, dying of lung cancer in 1996.

For its part, R.J. Reynolds denied the allegations and has indicated that it will appeal the verdict, according to the Time report.

The case was, at one time, one of thousands of tobacco claims to arise from the Engle v. Liggett Group Inc. case, a large class action lawsuit filed on behalf of Florida citizens who suffered from smoking-related illnesses in 1994 (Case No.: No. SC03-1856, Florida Supreme Court). In 2000, a jury returned a verdict for the Engle plaintiffs, including $145 billion in punitive damages. In 2004, an appellate court overturned the jury’s decision and reversed the award. In 2006, the Florida Supreme Court upheld the appellate court decision and de-certified the class; however, the Supreme Court ruled that members of the original lawsuit would be allowed to file individual lawsuits against tobacco companies using the findings from the Engle case that included that cigarette smoking causes cancer, that nicotine is addictive, and that tobacco companies sold defective and unreasonably dangerous cigarettes.

“We are happy that the justice system continues to recognize that cigarettes are dangerous,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “These verdicts should be sending a strong message to the tobacco industry.”

Parker Waichman LLP is a leading personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York; New Jersey; Florida; and Washington, D.C. For more than two decades, Parker Waichman LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective drugs, medical devices and other products. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Read the full story at http://www.prweb.com/releases/2014/07/prweb12047878.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Chinese Drywall Complaint Center Now Demands Leadership From Obama & EPA, For Homeowners In Florida And In The US Southeast Stuck In Toxic Chinese Drywall Hell-Forward?
2. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
3. Cleveland Clinic Florida receives approval for transplant programs at Weston Facilities
4. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
5. Florida Dentistry Office Whitens Teeth for Charity
6. Scripps Florida scientist awarded $2.5 million to study inner workings of memory formation
7. Nuvia Cafe to be Showcased at the Soho Expo in Orlando, Florida: December 8-9, 2012.
8. PVI Solar Installs The Largest Solar Powered Sign In The U.S. For A St. Petersburg, Florida Based Software Firm, Clairfire
9. Scripps Florida scientists develop new compound that reverses fatty liver disease
10. Scripps Florida scientists create new approach to destroy disease-associated RNAs in cells
11. Hearing and Balance Associates of NW Florida Releases New Website for Hearing Aids in Tallahassee FL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: